Immunology Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Cell Rep. 2020 Nov 10;33(6):108371. doi: 10.1016/j.celrep.2020.108371.
Transcription factor EB (TFEB) activates lysosomal biogenesis genes in response to environmental cues. Given implications of impaired TFEB signaling and lysosomal dysfunction in metabolic, neurological, and infectious diseases, we aim to systematically identify TFEB-directed circuits by examining transcriptional responses to TFEB subcellular localization and stimulation. We reveal that steady-state nuclear TFEB is sufficient to activate transcription of lysosomal, autophagy, and innate immunity genes, whereas other targets require higher thresholds of stimulation. Furthermore, we identify shared and distinct transcriptional signatures between mTOR inhibition and bacterial autophagy. Using a genome-wide CRISPR library, we find TFEB targets that protect cells from or sensitize cells to lysosomal cell death. BHLHE40 and BHLHE41, genes responsive to high, sustained levels of nuclear TFEB, act in opposition to TFEB upon lysosomal cell death induction. Further investigation identifies genes counter-regulated by TFEB and BHLHE40/41, adding this negative feedback to the current understanding of TFEB regulatory mechanisms.
转录因子 EB(TFEB)响应环境信号激活溶酶体生物发生基因。鉴于 TFEB 信号转导和溶酶体功能障碍在代谢、神经和传染病中的影响,我们旨在通过检查 TFEB 亚细胞定位和刺激的转录反应,系统地识别 TFEB 指导的回路。我们揭示稳态核 TFEB 足以激活溶酶体、自噬和先天免疫基因的转录,而其他靶标则需要更高的刺激阈值。此外,我们在 mTOR 抑制和细菌自噬之间发现了共同和独特的转录特征。使用全基因组 CRISPR 文库,我们找到了 TFEB 靶标,这些靶标可以保护细胞免受溶酶体细胞死亡或使细胞对溶酶体细胞死亡敏感。BHLHE40 和 BHLHE41 是对高水平、持续核 TFEB 有反应的基因,在溶酶体细胞死亡诱导时与 TFEB 作用相反。进一步的研究确定了 TFEB 和 BHLHE40/41 反向调节的基因,这为 TFEB 调节机制的现有理解增加了这种负反馈。